Triple threat: new malaria combo could outsmart drug resistance
NCT ID NCT05951595
First seen Nov 18, 2025 · Last updated May 20, 2026 · Updated 25 times
Summary
This study tests a new malaria pill that combines three drugs (artemether-lumefantrine-amodiaquine) to see if it works as well as the standard two-drug treatments. About 1,680 people with uncomplicated malaria will take either the new triple pill or a standard treatment and be followed for up to 42 days. The goal is to find a treatment that stays effective even as malaria parasites become resistant to current drugs.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ruhuha Health Centre
RECRUITINGRuhuha, Eastern Province, Rwanda
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.